FOX BIZ NEWS: Strong sales of drugs, vaccines, propel Merck in third quarter

Strong sales of drugs, vaccines, propel Merck in third quarter



The Kenilworth, New Jersey, company on Tuesday reported a profit of $1.16 per share. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, came to $1.74 per share.